MLF1IP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.511400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.821200E-01
Normal-vs-Stage2
3.104800E-01
Normal-vs-Stage3
4.524400E-01
Normal-vs-Stage4
7.038800E-01
Stage1-vs-Stage2
4.822600E-01
Stage1-vs-Stage3
8.259000E-01
Stage1-vs-Stage4
9.138200E-01
Stage2-vs-Stage3
7.544400E-01
Stage2-vs-Stage4
4.733200E-01
Stage3-vs-Stage4
6.896600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.302800E-01
Normal-vs-AfricanAmerican
7.661000E-01
Normal-vs-Asian
3.931800E-01
Caucasian-vs-AfricanAmerican
8.975600E-02
Caucasian-vs-Asian
8.903400E-01
AfricanAmerican-vs-Asian
1.356430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.260000E-01
Normal-vs-Female
2.853600E-01
Male-vs-Female
1.932990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.719000E-01
Normal-vs-Age(41-60Yrs)
3.669000E-01
Normal-vs-Age(61-80Yrs)
3.480400E-01
Normal-vs-Age(81-100Yrs)
1.942760E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.020400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.569800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.288410E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.710200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.680400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.837800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.645000E-01
Normal-vs-Daily Drinker
2.909400E-01
Normal-vs-Weekly Drinker
4.340200E-01
Normal-vs-Occasional Drinker
3.549200E-01
Normal-vs-Social Drinker
1.843550E-01
Non Drinker-vs-Daily Drinker
8.483800E-01
Non Drinker-vs-Weekly Drinker
6.922800E-01
Non Drinker-vs-Occasional Drinker
7.894800E-01
Non Drinker-vs-Social Drinker
8.184200E-01
Daily Drinker-vs-Weekly Drinker
6.393200E-01
Daily Drinker-vs-Occasional Drinker
9.167800E-01
Daily Drinker-vs-Social Drinker
6.401200E-01
Weekly Drinker-vs-Occasional Drinker
6.063800E-01
Weekly Drinker-vs-Social Drinker
8.471400E-01
Occasional Drinker-vs-Social Drinker
5.984800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.889200E-01
Normal-vs-Grade 2
6.583200E-01
Normal-vs-Grade 3
6.680800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.358640E-03
Grade 1-vs-Grade 3
1.137430E-03
Grade 1-vs-Grade 4
5.889200E-01
Grade 2-vs-Grade 3
6.812800E-01
Grade 2-vs-Grade 4
6.583200E-01
Grade 3-vs-Grade 4
6.680800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.174000E-01
Normal-vs-NonDiabetic
3.485400E-01
Diabetic-vs-NonDiabetic
4.149400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.818400E-02
Normal-vs-NoPancreatitis
3.997800E-01
Pancreatitis-vs-NoPancreatitis
1.785010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.813400E-01
Normal-vs-N1
3.090400E-01
N0-vs-N1
3.753600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.006380E-01
Normal-vs-TP53-NonMutant
4.702600E-01
TP53-Mutant-vs-TP53-NonMutant
1.220540E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
